Moderna becomes the latest coronavirus vaccine player to act on the need for a major manufacturing push.
What is biopharma doing to develop vaccines against Covid-19, and what are the properties of each approach? Vantage takes a look.
Biotech IPOs raised a huge $2.3bn on Western exchanges in the second-quarter of 2018, as private companies rushed to market ahead of the summer lull.
Eagerly pursuing all the latest fads and trends.